N
NeuroClues
The brain stethoscope providing CNS biomarkers in a Blink
About NeuroClues
neuroClues (powered by P3Lab) is a French-Belgian MedTech company founded in 2020 by Antoine Pouppez, Pierre Daye and Pierre Pouget. It develops a compact, CE-marked Class IIa medical device that records high-speed infrared eye movements during simple visual tasks and extracts objective neurological biomarkers to help clinicians assess anomalies earlier than traditional observation or costly imaging—positioned as a “stethoscope for the brain” for Parkinson’s, Alzheimer’s and related disorders. After CE certification in January 2025 and 30+ deployments across Europe, neuroClues raised a €10 million Series A in April 2026 led by Teampact Ventures, White Fund and the EIC Fund, with InvestBW, Leansquare, Wallonie Entreprendre and support from Olivier Legrain (IBA); with additional non-dilutive capital, total funding reaches €25 million. Sources: EU-Startups 7 Apr 2026.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- Ottignies-Louvain-la-Neuve, Belgium
- Employees
- 35
- Open positions
- None listed
- Dealroom signal
- 80.9/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Biomarkers
- Technology
- Artificial Intelligence, Hardware, Big Data, Deep Tech, Computer Vision, Connected Device
- Business model
- Manufacturing, SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBT✓Debt | Apr 2026 | $0 | — | Undisclosed | ↗ |
| SERIES A✓Equity / VC | Apr 2026 | $11M | $44M | Olivier Legrain · Wallonie Entreprendre · EIC Fund · Teampact Ventures | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for NeuroClues is 3.1K monthly website visits, up 158.3% over the last three months. NeuroClues's team grew 12.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed6 investors entered at this stage
European Innovation Council
White fund
Olivier Legrain
Wallonie Entreprendre
Fiona du Monceau - de Hemptinne
WE Venture
Series A7 investors entered at this stage
Graph Ventures
Invest.BW
Jean-Charles Samuelian
Wing
EIC Fund
Teampact Ventures
LeanSquare
Other known investors1 additional known investor
EIT Health
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about NeuroClues on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See NeuroClues’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.